Status:
UNKNOWN
The Evaluation of Anti-interference Ability and Clinical Specificity of HIV Ag +Ab Assay Kit (Sysmex)
Lead Sponsor:
Qianfoshan Hospital
Conditions:
HIV Seropositivity
Cancer
Eligibility:
All Genders
18-100 years
Brief Summary
To evaluate the anti-interference and specificity of HIV Ag +Ab Assay Kit (Sysmex) for the detection of HIV antigens and antibodies.
Detailed Description
First,HIV Ag +Ab Assay Kit (Sysmex)Assay Kit (Sysmex) was used to detect HIV antigens and antibodies in the serum of patients with tumor and blood diseases, and then confirmed by using the gold standa...
Eligibility Criteria
Inclusion
- Clinical diagnosis of tumor Disease or blood disease
- Blood samples must meet the test requirements
Exclusion
- N/A
Key Trial Info
Start Date :
September 20 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2025
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT05983536
Start Date
September 20 2023
End Date
July 31 2025
Last Update
August 9 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.